Images obtained early (4 h, left) and late (48 h, right) after administration of ibritumomab tiuxetan show decrease in blood pool over time and uptake in inguinal lymph nodes and brain at 48 h. Submitted by Jeanne Moceri, MSA, CNMT, Henry Ford Hospital, Detroit, MI.